Suzanne Lentzsch
CUIMC/Herbert Irving Pavilion
Office
(212) 305-5098
161 Fort Washington Avenue New York, NY 10032
About
Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia.
Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation "Black Swan Research Initiative" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.
Suzanne Lentzsch
Dr. Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York. She is at New York Presbyterian Hospital/ Columbia University Medical Center. After receiving her degrees from the Humboldt University/ Charité Berlin, Germany, she completed her residency and fellowship at Humboldt University. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, MA, USA.Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia.
Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation "Black Swan Research Initiative" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.
Primary Specialty
Oncologist
Practice
CUIMC/Herbert Irving Pavilion
Gender
Female
Accepting New Patients
Insurances Accepted
UnitedHealthcare, Empire Blue Cross/Blue Shield, CIGNA, AETNA, Multiplan, Local 1199, VNSNY CHOICE, Emblem/Hip, Fidelis Care, Medicare, WellCare, Emblem/GHI, RiverSpring, World Trade Center Health Plan, Healthfirst, MVP Health Care, Affinity Health Plan, Magnacare (National), Empire Blue Cross Blue Shield Healthplus, Amida Care
Degrees
Medical Doctor, Doctor of Philosophy
Office Name
CUIMC/Herbert Irving Pavilion
Languages
German
Services
CUIMC/Herbert Irving Pavilion provides oncology services in New York, NY. Oncology includes the diagnosis and treatment of breast cancer, skin cancer, prostate cancer, and many other forms of cancer.
Contact Suzanne Lentzsch at (212) 305-5098 for specific information about cancer treatment in New York, NY. Additional Services Hematologist, Doctor
Contact Suzanne Lentzsch at (212) 305-5098 for specific information about cancer treatment in New York, NY. Additional Services Hematologist, Doctor
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!
©2025 Wellness®.com is a registered trademark of Wellness.com, Inc. 